Get started
Author

Gabriella Gálffy

Observed names: G Galffy, G Gálffy, G. Galffy, G. Gallfy, G. Gálffy, G. Székelyné Galffy, GABRIELLA GALFFY, Gabriella Galffy, Gabriella Gállfy, Galffy Gabriella, Gálffy Gabriella, Gálffy, Gabriella
Observed institutions: Semmelweis University, The University of Texas MD Anderson Cancer Center, Wakayama Medical University, Károli Gáspár University of the Reformed Church in Hungary, Protestant Theological Institute of Cluj-Napoca, Wuhan Pulmonary Hospital, Duke Medical Center, Provincial Polyclinical Hospital in Toruń, Duke Cancer Institute, Indiana University School of Medicine, Imperial College London, Hungarian Academy of Sciences, Kindai University
ORCID: 0000-0001-7255-035X
Observed ORCID: 0000-0001-7255-035X
OpenAlex ID: A5069675443
Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer
2023 · John V. Heymach, David Harpole, et al. · New England Journal of Medicine · 936
PDF
U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics
2016 · Diane Lefaudeux, Bertrand De Meulder, et al. · Journal of Allergy and Clinical Immunology · 305
PDF
Molecular profiles of small cell lung cancer subtypes: Therapeutic implications
2021 · Anna Schwendenwein, Zsolt Megyesfalvi, et al. · Molecular Therapy — Oncolytics · 147
PDF
IL-17–high asthma with features of a psoriasis immunophenotype
2019 · Jörgen Östling, Marleen van Geest, et al. · Journal of Allergy and Clinical Immunology · 128
PDF
Distinct composition and metabolic functions of human gut microbiota are associated with cachexia in lung cancer patients
2021 · Yueqiong Ni, Zoltan Lohinai, et al. · The ISME Journal · 125
PDF
Interleukin 8: an autocrine growth factor for malignant mesothelioma.
1999 · G Galffy, K A Mohammed, et al. · PubMed · 113
Expression patterns and prognostic relevance of subtype‐specific transcription factors in surgically resected small‐cell lung cancer: an international multicenter study
2022 · Zsolt Megyesfalvi, Nandor Barany, et al. · The Journal of Pathology · 106
PDF
Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non–Small Cell Lung Cancer: The Phase III PACIFIC-2 Study
2025 · Jeffrey D. Bradley, Shunichi Sugawara, et al. · Journal of Clinical Oncology · 97
Abstract CT005: AEGEAN: A phase 3 trial of neoadjuvant durvalumab + chemotherapy followed by adjuvant durvalumab in patients with resectable NSCLC
2023 · John V. Heymach, David Harpole, et al. · Cancer Research · 89
Stratification of asthma phenotypes by airway proteomic signatures
2019 · James P.R. Schofield, Dominic Burg, et al. · Journal of Allergy and Clinical Immunology · 88
PDF
Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation
2011 · Veronika Müller, Gabriella Gálffy, et al. · BMC Pulmonary Medicine · 84
PDF
Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study
2022 · Tessa M Kole, Elise Vanden Berghe, et al. · The Lancet Respiratory Medicine · 80
PDF
Talc Induces Apoptosis in Human Malignant Mesothelioma Cells In Vitro
2000 · NAJMUNNISA NASREEN, KAMAL A. MOHAMMED, et al. · American Journal of Respiratory and Critical Care Medicine · 80
Prevalence of allergic rhinitis, related comorbidities and risk factors in schoolchildren
2020 · Monika Sultész, Alpár Horváth, et al. · Allergy Asthma and Clinical Immunology · 72
Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 status
2023 · David Dora, Balazs Ligeti, et al. · OncoImmunology · 63
PDF
Evaluation of a Partial Genome Screening of Two Asthma Susceptibility Regions Using Bayesian Network Based Bayesian Multilevel Analysis of Relevance
2012 · Ildikó Ungvári, Gábor Hullám, et al. · PLoS ONE · 59
PDF
Targeted therapeutic options in early and metastatic NSCLC-overview
2024 · Gabriella Gálffy, Éva Morócz, et al. · Pathology & Oncology Research · 57
PDF
Candida expansion in the gut of lung cancer patients associates with an ecological signature that supports growth under dysbiotic conditions
2023 · Bastian Seelbinder, Zoltan Lohinai, et al. · Nature Communications · 55
PDF
RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer
2024 · David R. Spigel, Afshin Dowlati, et al. · Journal of Clinical Oncology · 49
Implication of BIRC5 in asthma pathogenesis
2012 · I. Ungvari, E. Hadadi, et al. · International Immunology · 48
Prevalence and risk factors for allergic rhinitis in primary schoolchildren in Budapest
2010 · Monika Sultész, Gábor Katona, et al. · International Journal of Pediatric Otorhinolaryngology · 44
Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From Hungary
2019 · Krisztina Bogos, Zoltán Kiss, et al. · Frontiers in Oncology · 40
PDF
EGFR variant allele frequency predicts EGFR-TKI efficacy in lung adenocarcinoma: a multicenter study
2021 · Balazs Gieszer, Zsolt Megyesfalvi, et al. · Translational Lung Cancer Research · 38
PDF
Plasma neutrophil extracellular trap level is modified by disease severity and inhaled corticosteroids in chronic inflammatory lung diseases
2020 · Zsófia Gál, András Gézsi, et al. · Scientific Reports · 37
PDF
Investigation of the Possible Role of the Hippo/YAP1 Pathway in Asthma and Allergy
2017 · Lili E. Fodor, András Gézsi, et al. · Allergy Asthma and Immunology Research · 37
PDF
Works count: 213
Citation count: 4,166
H-index: 31
I10-index: 76
Year
Topic
Type